Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,226 | 284 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Collegium Pharmaceutical, Inc. | $1,670 | 106 | $0 (2024) |
| Nevro Corp. | $449.97 | 24 | $0 (2024) |
| Abbott Laboratories | $340.28 | 9 | $0 (2021) |
| Purdue Pharma L.P. | $287.86 | 17 | $0 (2018) |
| Daiichi Sankyo Inc. | $252.11 | 10 | $0 (2018) |
| Medtronic, Inc. | $243.61 | 5 | $0 (2024) |
| PFIZER INC. | $221.80 | 15 | $0 (2021) |
| Amgen Inc. | $200.41 | 14 | $0 (2022) |
| Boston Scientific Corporation | $185.45 | 5 | $0 (2021) |
| SI-BONE, Inc. | $163.57 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $460.30 | 28 | Collegium Pharmaceutical, Inc. ($291.08) |
| 2023 | $684.89 | 33 | Collegium Pharmaceutical, Inc. ($243.05) |
| 2022 | $436.44 | 31 | Collegium Pharmaceutical, Inc. ($195.05) |
| 2021 | $462.42 | 27 | Collegium Pharmaceutical, Inc. ($209.26) |
| 2020 | $538.84 | 35 | Collegium Pharmaceutical, Inc. ($163.63) |
| 2019 | $516.99 | 29 | Collegium Pharmaceutical, Inc. ($124.70) |
| 2018 | $885.56 | 40 | Collegium Pharmaceutical, Inc. ($223.32) |
| 2017 | $1,240 | 61 | Purdue Pharma L.P. ($244.48) |
All Payment Transactions
284 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/22/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $20.81 | General |
| Category: Opioid Analgesic | ||||||
| 11/08/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.58 | General |
| Category: Opioid Analgesic | ||||||
| 10/25/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.85 | General |
| Category: Opioid Analgesic | ||||||
| 09/30/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $13.40 | General |
| Category: Opioid Analgesic | ||||||
| 09/16/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/12/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $8.79 | General |
| Category: Opioid Analgesic | ||||||
| 08/28/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $7.36 | General |
| Category: Opioid Analgesic | ||||||
| 08/20/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.82 | General |
| Category: Opioid Analgesic | ||||||
| 08/01/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/29/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.01 | General |
| Category: Opioid Analgesic | ||||||
| 07/15/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $8.56 | General |
| Category: Opioid Analgesic | ||||||
| 07/01/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.84 | General |
| Category: Opioid Analgesic | ||||||
| 06/14/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $21.14 | General |
| Category: Opioid Analgesic | ||||||
| 06/06/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $6.41 | General |
| Category: Opioid Analgesic | ||||||
| 06/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Gastroenterology | ||||||
| 05/24/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.22 | General |
| Category: Opioid Analgesic | ||||||
| 05/17/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $6.51 | General |
| Category: Opioid Analgesic | ||||||
| 05/16/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/11/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.35 | General |
| Category: Opioid Analgesic | ||||||
| 04/12/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.96 | General |
| Category: Opioid Analgesic | ||||||
| 03/18/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 03/15/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $20.87 | General |
| Category: Opioid Analgesic | ||||||
| 03/01/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $5.28 | General |
| Category: Opioid Analgesic | ||||||
| 02/27/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Spinal Cord Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 589 | 1,207 | $455,536 | $90,220 |
| 2022 | 12 | 770 | 1,198 | $552,123 | $84,435 |
| 2021 | 19 | 1,275 | 2,377 | $1.3M | $187,086 |
| 2020 | 19 | 1,191 | 2,226 | $1.2M | $157,242 |
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 223 | 653 | $155,995 | $44,797 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 162 | $56,794 | $15,515 | 27.3% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 70 | 146 | $119,421 | $11,396 | 9.5% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 24 | 50 | $41,630 | $4,218 | 10.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $11,343 | $2,759 | 24.3% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 22 | 29 | $15,377 | $2,389 | 15.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 15 | 22 | $12,533 | $2,214 | 17.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $8,564 | $1,994 | 23.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 17 | 21 | $4,731 | $1,477 | 31.2% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 12 | 17 | $18,979 | $1,424 | 7.5% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 12 | 16 | $4,553 | $955.51 | 21.0% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 13 | 20 | $3,662 | $832.00 | 22.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 23 | $1,955 | $250.69 | 12.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 237 | 449 | $207,628 | $37,696 | 18.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 177 | 278 | $81,411 | $15,536 | 19.1% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2022 | 29 | 55 | $46,750 | $10,006 | 21.4% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2022 | 59 | 108 | $90,390 | $8,112 | 9.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $31,115 | $5,068 | 16.3% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 12 | 19 | $56,961 | $3,170 | 5.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 23 | 28 | $8,274 | $1,402 | 16.9% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 97 | 98 | $12,250 | $1,219 | 10.0% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2022 | 12 | 14 | $9,137 | $1,005 | 11.0% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2022 | 14 | 20 | $4,890 | $801.50 | 16.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 20 | 23 | $2,465 | $216.10 | 8.8% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 30 | 42 | $672.00 | $196.48 | 29.2% |
About Dr. Jay Wright, MD
Dr. Jay Wright, MD is a Specialist healthcare provider based in Ocoee, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265537476.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jay Wright, MD has received a total of $5,226 in payments from pharmaceutical and medical device companies, with $460.30 received in 2024. These payments were reported across 284 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($5,226).
As a Medicare-enrolled provider, Wright has provided services to 3,825 Medicare beneficiaries, totaling 7,008 services with total Medicare billing of $518,982. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Pain Medicine
- Location Ocoee, FL
- Active Since 09/13/2006
- Last Updated 01/24/2025
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1265537476
Products in Payments
- XTAMPZA (Drug) $1,275
- Xtampza ER (Drug) $342.15
- Senza (Device) $255.29
- INTELLIS ADAPTIVESTIM (Device) $243.61
- Movantik (Drug) $199.12
- SPECTRA WAVEWRITER (Device) $173.21
- iFuse Implant (Device) $163.57
- EUFLEXXA (Device) $161.77
- EVENITY (Biological) $157.81
- HYSINGLA ER (Drug) $153.85
- Radiofrequency Therapy (Device) $140.92
- INTELLIS (Device) $139.23
- RELISTOR (Drug) $129.85
- Omnia (Device) $119.71
- LYRICA (Drug) $101.29
- ZTLido (Drug) $100.64
- SCS IPGs (Device) $94.57
- Tymlos (Biological) $91.92
- Proclaim Family of SCS IPGs (Device) $82.90
- OXYCONTIN (Drug) $78.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Ocoee
Mrs. Alka Arora, M.d, M.D
Specialist — Payments: $3,792
Dr. Jose Torres, M.d, M.D
Specialist — Payments: $1,733
Anne Carter, Md, MD
Specialist — Payments: $1,121
Harry Agis, M.d, M.D
Specialist — Payments: $794.04
William Cox, M.d, M.D
Specialist — Payments: $702.01
Dr. Ammar Saati, M.d, M.D
Specialist — Payments: $348.39